Literature DB >> 29475915

Reduced Peripheral Blood Mononuclear Cell ROCK1 and ROCK2 Levels in Obstructive Sleep Apnea Syndrome.

Şenay Aydin1, Cengiz Özdemir2, Cem Ismail Küçükali3, Sinem Nedime Sökücü2, Murat Giriş3, Uğur Akcan3, Erdem Tüzün4.   

Abstract

BACKGROUND/AIM: Obstructive sleep apnea syndrome (OSAS) is associated with intermittent episodes of hypoxia, endothelial dysfunction and associated cardiovascular problems. Our aim was to investigate whether OSAS-related hypoxia alters the expression of rho-associated protein kinase (ROCK), a marker of chronic hypoxia and endothelial dysfunction.
MATERIALS AND METHODS: ROCK1 and ROCK2 levels were measured by immunoblotting in peripheral blood mononuclear cells (PBMC) of 47 OSAS patients and 17 healthy controls.
RESULTS: OSAS patients showed significantly lower PBMC ROCK1 and ROCK2 levels than healthy controls in the morning, but not in the evening. ROCK1/2 levels were correlated with blood triglyceride, visceral adiposity index, minimum oxygen saturation, C-reactive protein concentration, lymphocyte levels and sleep efficiency.
CONCLUSION: Intermittent hypoxia induced by OSAS does not permanently alter ROCK protein expression levels. OSAS appears to be associated with endothelial dysfunction through inflammation and lipid metabolism pathways. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Obstructive sleep apnea syndrome; ROCK; polysomnography; rho-associated protein kinase; sleep; triglycerides

Mesh:

Substances:

Year:  2018        PMID: 29475915      PMCID: PMC5905200          DOI: 10.21873/invivo.11240

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  29 in total

Review 1.  Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.

Authors:  Jianjian Shi; Lei Wei
Journal:  J Cardiovasc Pharmacol       Date:  2013-10       Impact factor: 3.105

Review 2.  Rho kinase inhibition in diabetic kidney disease.

Authors:  Radko Komers
Journal:  Br J Clin Pharmacol       Date:  2013-10       Impact factor: 4.335

Review 3.  Type 2 diabetes as an inflammatory disease.

Authors:  Marc Y Donath; Steven E Shoelson
Journal:  Nat Rev Immunol       Date:  2011-01-14       Impact factor: 53.106

4.  Rho kinase inhibition by fasudil has anti-inflammatory effects in hypercholesterolemic rats.

Authors:  Zhihong Ma; Jianping Zhang; Rongpin Du; Ensheng Ji; Li Chu
Journal:  Biol Pharm Bull       Date:  2011       Impact factor: 2.233

Review 5.  Sleep Apnea: Types, Mechanisms, and Clinical Cardiovascular Consequences.

Authors:  Shahrokh Javaheri; Ferran Barbe; Francisco Campos-Rodriguez; Jerome A Dempsey; Rami Khayat; Sogol Javaheri; Atul Malhotra; Miguel A Martinez-Garcia; Reena Mehra; Allan I Pack; Vsevolod Y Polotsky; Susan Redline; Virend K Somers
Journal:  J Am Coll Cardiol       Date:  2017-02-21       Impact factor: 24.094

6.  The occurrence of sleep-disordered breathing among middle-aged adults.

Authors:  T Young; M Palta; J Dempsey; J Skatrud; S Weber; S Badr
Journal:  N Engl J Med       Date:  1993-04-29       Impact factor: 91.245

7.  A combination of increased Rho kinase activity and N-terminal pro-B-type natriuretic peptide predicts worse cardiovascular outcome in patients with acute coronary syndrome.

Authors:  Ming Dong; James K Liao; Bryan Yan; Ruijie Li; Mang Zhang; Cheuk-Man Yu
Journal:  Int J Cardiol       Date:  2012-08-24       Impact factor: 4.164

8.  A community study of sleep-disordered breathing in middle-aged Chinese women in Hong Kong: prevalence and gender differences.

Authors:  Mary S M Ip; Bing Lam; Lawrence C H Tang; Ian J Lauder; Toi Yan Ip; Wah Kit Lam
Journal:  Chest       Date:  2004-01       Impact factor: 9.410

9.  Snoring and sleep apnea. A population study in Australian men.

Authors:  H Bearpark; L Elliott; R Grunstein; S Cullen; H Schneider; W Althaus; C Sullivan
Journal:  Am J Respir Crit Care Med       Date:  1995-05       Impact factor: 21.405

Review 10.  Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report.

Authors:  Timothy I Morgenthaler; Teofilo Lee-Chiong; Cathy Alessi; Leah Friedman; R Nisha Aurora; Brian Boehlecke; Terry Brown; Andrew L Chesson; Vishesh Kapur; Rama Maganti; Judith Owens; Jeffrey Pancer; Todd J Swick; Rochelle Zak
Journal:  Sleep       Date:  2007-11       Impact factor: 5.849

View more
  1 in total

1.  Research on the Association Between Obstructive Sleep Apnea Hypopnea Syndrome Complicated With Coronary Heart Disease and Inflammatory Factors, Glycolipid Metabolism, Obesity, and Insulin Resistance.

Authors:  Yumei Wen; Haibin Zhang; Yu Tang; Rui Yan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-01       Impact factor: 6.055

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.